Cargando…

Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy

Perianal fistulas can occur to up to one-third of patients with Crohn’s disease (CD) leading to significant disabling disease and morbidity. Fistulising perianal CD treatment often necessitates a combined pharmacological and surgical approach. Anti-tumor necrosis factor (anti-TNF) therapy, particula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papamichael, Konstantinos, Cheifetz, Adam S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603485/ https://www.ncbi.nlm.nih.gov/pubmed/28974885 http://dx.doi.org/10.3748/wjg.v23.i34.6197

Ejemplares similares

Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease
por: Thomassin, Lucie, et al.
Publicado: (2017)

The Bottom Line: A Multidisciplinary Approach Is Key to Treating Perianal Fistulizing Crohn’s Disease
por: Nguyen, Geoffrey C
Publicado: (2018)

Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018)

Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022)

Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)

Establishing a rabbit model of perianal fistulizing Crohn’s disease
por: Lu, Shuang-Shuang, et al.
Publicado: (2022)

Analysis of Risk Factors for Anorectal Stenosis of Perianal Fistulizing Crohn’s Disease
por: Xu, MinMin, et al.
Publicado: (2020)

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
por: Ayoub, Fares, et al.
Publicado: (2022)

Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era
por: Lee, Tanya, et al.
Publicado: (2020)

Perianal fistulizing Crohn's disease and overall risk of cancer: No red flag
por: McLellan, Paul, et al.
Publicado: (2023)

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
por: Yan, Xiaohan, et al.
Publicado: (2019)

Prognostic factors affecting outcomes in fistulating perianal Crohn’s disease: a systematic review
por: Braithwaite, G. C., et al.
Publicado: (2017)

Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis
por: Lee, Tanya, et al.
Publicado: (2019)

Editorial: Abdominal and Perianal Fistulizing Crohn's Disease: Imaging, Surgical Techniques and Basic Research
por: Luglio, Gaetano, et al.
Publicado: (2022)

A Preclinical Validation of Iron Oxide Nanoparticles for Treatment of Perianal Fistulizing Crohn’s Disease
por: Cazelles, Antoine, et al.
Publicado: (2022)

Clinical characteristics and MRI-based phenotypes of perianal abscess formation in children with fistulizing Crohn's Disease
por: Tabari, Azadeh, et al.
Publicado: (2022)

A complex presentation and successful management of fistulizing perianal Crohn’s disease extending to the mid-back
por: Vazquez, Christopher, et al.
Publicado: (2023)

Internal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease
por: Fang, Xiaoli, et al.
Publicado: (2023)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

Surgical Treatment of Perianal Fistulizing Crohn's Disease: From Lay-Open to Cell-Based Therapy—An Overview
por: Pellino, Gianluca, et al.
Publicado: (2014)

Multidrug Resistance and Flaring up of Manifestation in Fistulizing Crohn's Disease after Surgery on a Perianal Lesion
por: Ali, Abeer S., et al.
Publicado: (2021)

Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?
por: Armuzzi, Alessandro, et al.
Publicado: (2022)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn’s Disease Patients
por: van Rijn, Kyra L, et al.
Publicado: (2021)

Association Between Steroid-Sparing Therapy and the Risk of Perianal Fistulizing Complications Among Young Patients With Crohn Disease
por: Adler, Jeremy, et al.
Publicado: (2020)

Disease- and Medication-Specific Differences of the Microbial Spectrum in Perianal Fistulizing Crohn’s Disease—Relevant Aspects for Antibiotic Therapy
por: Kelm, Matthias, et al.
Publicado: (2022)

Ustekinumab Promotes Radiological Fistula Healing in Perianal Fistulizing Crohn’s Disease: A Retrospective Real-World Analysis
por: Yao, Jiayin, et al.
Publicado: (2023)

Risk of Repeat Surgery for Perianal Crohn Disease
por: Lee, Doo Han
Publicado: (2015)

Korean Children and Adolescents with Crohn's Disease Are More Likely to Present with Perianal Fistulizing Disease at Diagnosis Compared to Their European Counterparts
por: Kang, Ben, et al.
Publicado: (2020)

Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn′s Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition
por: Rizzo, Giulia, et al.
Publicado: (2022)

Perianal fistulizing Crohn's disease is associated with a higher prevalence of HPV in the anorectal fistula tract. A comparative study
por: Boarini, Lucas Rodrigues, et al.
Publicado: (2023)

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis
por: Zaboli, Pardis, et al.
Publicado: (2017)

Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?
por: Im, Jong Pil
Publicado: (2017)

Food for Thought: Remission of Perianal Pediatric Crohn’s Disease on Specific Carbohydrate Diet Monotherapy
por: Simon, David, et al.
Publicado: (2023)

Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn’s disease: a narrative review
por: Miranda, Eron Fabio, et al.
Publicado: (2021)

Clinical profiles of moderate and severe Crohn’s disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines
por: Mantzaris, Gerassimos J., et al.
Publicado: (2015)

Anti-tumor Necrosis Factor Therapy for Crohn Disease: Friend or Foe to the Surgeon?
por: Kim, Hungdai
Publicado: (2015)

Pathogenesis of Fistulating Crohn’s Disease: A Review
por: McGregor, Colleen Georgette Chantelle, et al.
Publicado: (2022)

Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
por: Ye, Byong Duk
Publicado: (2014)

Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
por: Lee, Jong Lyul
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ndf1qlo3mci15m4ho4becsh44s